With the RegMed Forum we aim to identify those shortcomings that currently block or hinder advanced and regenerative therapies to become leading strategies in health care. We believe that a patient-centric view should be at the core of our discussion and, thus, the forum brings together all stakeholders involved from patient representatives, healthcare providers, regulatory authorities, scientists, start-ups and big pharma. They will share their expertise and opinions in talks, panel discussions and dedicated round tables. Furthermore, there will be plenty of networking opportunities aiming to reach a consensus understanding on the essential patient-centric outcome measures and the requirements of a patient-centric view. Such way, the implementation of advanced therapies could prove effective despite their sometimes higher initial costs.
What to expect?
- Talks & panel discussions with different stakeholders.
- Round table discussions in breakout-sessions on specific topics.
- Onsite industry exhibition to present your products and services.
- Plenty of onsite networking opportunity.
Who will be attending?
Patient representatives, healthcare providers, regulatory authorities, scientists, start-ups and big pharma from Germany and beyond interested in developing essential outcome measures and requirements in a patient-centric view that could help to support pre-clinical and clinical work to enable broader applications of advanced therapies in various indications.
The event is free of charge.